Hans Langendijk

Prof. dr. Hans Langendijk is a Professor and Chair of the Department of Radiation Oncology at the University of Groningen's Faculty of Medical Sciences. He holds additional roles including Chair of the Oncology Division at UMCG and membership in international advisory boards such as the Danish Center for Particle Therapy and the EU HARMONIC project. His research focuses on Radiation Oncology, particularly in Head and Neck Oncology and Proton Therapy applications. He has contributed to advancements in normal tissue complication probability (NTCP) modeling and radiation-induced toxicity studies. Notable awards include the Jens Overgaard Legacy Award and the Carl Krebs Award.

His research spans topics like subclinical cardiac dysfunction post-irradiation, proton therapy dosimetry, and predictive modeling for treatment outcomes. Langendijk has been actively involved in international collaborations, including studies on proton therapy efficacy and radiation-induced complications. He has supervised 40+ academic works and contributed to numerous peer-reviewed publications in journals like Radiology: Cardiothoracic Imaging and Radiotherapy and Oncology.

Awards include recognition for his contributions to radiation oncology and clinical research. His work aligns with UN Sustainable Development Goals related to health and well-being, emphasizing evidence-based practices in oncology treatment and patient outcomes.